Vinceti et al. reported that higher levels of selenoprotein P in the cerebrospinal fluid are linked to a lower risk of sporadic amyotrophic lateral sclerosis (ALS), whereas elevated selenite in the cerebrospinal fluid is linked to a higher risk of neurodegeneration [36]. Here, SELENOP is linked to amyotrophic lateral sclerosis.